baber/WOPTO huggingface dataset:
Patent CA-2520054-A1 (CA)
Title: Liquid foam systems and astm e-84 class 1 rated rigid, high-density polyurethane foams and articles prepared therefrom
Inventor: HERALDO JOHN
IPC: C08G18/48
Filed: 2005-09-16
Abstract: An all-liquid foam-forming system contains:   a first part (A) containing at least one liquid isocyanate or polyisocyanate;  and a second part (B) containing: at least one liquid aromatic polyester polyol having an hydroxyl value of at least 110 mg KOH/gram and an average hydroxyl functionality of at least 2, at least two liquid halogenated flame retardants and water;   the foam-forming system having an NCO/OH ratio of from about 0.9:1 to about 1.3:1;   wherein the first and second parts are such that reaction therebetween forms a rigid polyurethane foam having a density of at least about 5 pcf and an ASTM E-84 Class 1 rating.   Resultant polyurethane foams can be used to make articles, particularly for use in commercial decorative molding applications.
Patent CA-2520536-A1 (CA)
Title: Molding device
Inventor: HANSEN BERND
IPC: B29C48/92
Filed: 2004-01-24
Abstract: The invention relates to a molding device for moving at least one molding tool (10), especially for generating head geometries in plastic containers, by means of a link motion (22) which brings the respective molding tool (10) into the closed position at least for closing the tool. Said link motion (22) is actuated by a drive (24). The link motion allows for a novel drive and kinematic concept for the respective molding tool which allows to completely avoid hydraulic drive means. The drive is preferably an electric drive, especially a step motor.
Patent CA-2526435-A1 (CA)
Title: Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
Inventor: ANGOT STEPHANIE
IPC: A61K47/48
Filed: 2004-05-28
Abstract: La présente invention concerne des nouveaux matériaux à base de polyaminoacides biodégradables, utiles notamment pour la vectorisation de principe(s) actifs) (PA). L'invention vise aussi de nouvelles compositions pharmaceutiques, cosmétiques, diététiques ou phytosanitaires à base de ces polyaminoacides. Le but de l'invention est de fournir une nouvelle matière première polymère, susceptible d'être utilisée pour la vectorisation de PA e t permettant de satisfaire de manière optimale à toutes les spécifications requises en l'espèce : biocompatibilité, biodégradabilité, stabilité, aptitu de à s'associer facilement avec de nombreux principes actifs ou à les solubiliser, et à libérer ces principes actifs in vivo. Ce but est atteint p ar la présente invention qui concerne tout d'abord des polyaminoacides comprena nt des unités aspartiques et/ou des unités glutamiques, dont certaines sont porteuses d'au moins un greffon, caractérisé en ce qu'au moins un de ces greffons est relié à une unité aspartique ou glutamique, par l'intermédiaire d'un espaceur "acide aminé" à base de Leu, et/ou lieu, et/ou Val, et/ou Phe et en ce que un groupement hydrophobe en C6-C30 est relié par une liaison ester à l'espaceur. Ces espaceurs "acide aminé" spécifiques assurent une meilleure stabilité à l'hydrolyse et un taux d'association avec des protéines plus éle vé en comparaison avec les produits analogues de l'art antérieur. Avantageusement, ces polymères sont aussi aptes à se transformer aisément et économiquement en particules de vectorisation de principes actifs, ces particules étant elles même propres à former des suspensions colloïdales aqueuses stables.
Patent CA-2528421-A1 (CA)
Title: Airlaid method with an improved through-put rate
Inventor: SCHMIDT-FOERST ALEXANDER
IPC: D04H1/42
Filed: 2004-06-15
Abstract: The invention relates to a method for the production of a non-woven fibre according to an aerodynamic method, having an improved through-put rate. The invention also relates to a non-woven fibre produced according to said method, and to a short fibre which is suitable for use in said method.
Patent CA-2528741-A1 (CA)
Inventor: KEON RICHARD
IPC: A01H1/00
Filed: 2004-06-17
Abstract: Methods for the production of insulin in plants are described. In one embodiment, the present invention provides a method for the expression of insulin in plants comprising: (a) providing a chimeric nucleic acid construct comprising in the 5~ supl; to 3~ direction of transcription as operably linked components: (i) a nucleic acid sequence capable of controlling expression in plant seed cells; and (ii) a nucleic acid sequence encoding an insulin polypeptide; (b) introducing the chimeric nucleic acid construct into a plant cell; and (c) growing the plant cell into a mature plant capable of setting seed wherein the seed expresses insulin.
Patent CA-2532864-A1 (CA)
Inventor: HESS CHRISTIAN
IPC: G01N21/65
Filed: 2004-07-28
Abstract: Methods for assembly of monolayers of nanoparticles using the Langmuir-Blodgett technique, as well as monolayers, assemblies, and devices are described. The surface properties of these monolayers are highly reproducible and well-defined as compared to other systems. These monolayers can readily be used for molecular detection in either an air-borne or a solution environment, and sensors using the monolayer could have significant implications in chemical and biological warfare detection, national and global security, as well as in medical detection applications.
Patent CA-2535451-A1 (CA)
Title: Method of treating viral infections
Inventor: SMITH HOWARD J
IPC: A61K31/7056
Filed: 2004-08-03
Abstract: A method of pharmaceutical therapy comprising the co-administration of any form of interferon or any derivative thereof with a low dose of ribavirin (less than 400 mg /day or less than 6 mg/kg/day), or related compound, where the ribavirin or related compound provides a clinically effective blood level in the portal circulation but a less than clinically effective blood level in the peripheral circulation, to thereby provide a systemic effect of interferon throughout the body but a selective effect of ribavirin in the liver. The method also provides for the co-administration of any form of interferon or any derivative thereof with a high dose of ribavirin (preferably from 400-800 mg/day), or related compound, where the ribavirin or related compound is administered as a slow-release formulation such that it also provides a sustained virologic response in a patient and reduced side effects. The method also provides for the co-administration of an antioxidant or other membrane protective agent with both the interferon and ribavirin such that the hepatoprotective activity of the antioxidant or other membrane protective agent complements the virucidal effect of the interferon and ribavirin. The antioxidant or other membrane protective agent may be administered as a systemic or a low-dose, slow-release, liver-selective formulation.
Patent CA-2538453-A1 (CA)
Title: System and method for implementing a physical fitness regimen with color healing
Inventor: LEON CHRISTINA
IPC: A63B26/00
Filed: 2006-03-02
Abstract: A system and method for implementing a physical fitness regimen method with color healing in a manner that synergistically affects one or more of the seven chakras of the human body. The method comprises selecting at least one physical fitness activity to be performed by a person in a fitness area during a predetermined activity period. Further, the method comprises selecting a color environment to be produced in the fitness area during the predetermined activity period. The method may also include the selection of an aural environment to be produced in the fitness area during the predetermined activity period. The system comprises a color generator, to produce the color environment, an audio generator, to produce the aural environment, and a main control unit to synchronize the actuation of each.
Patent CA-2540102-A1 (CA)
Title: A combination of candesartan and rosuvastatin for the treatment of atherosclerosis
Inventor: MEHTA JAY LAL
IPC: A61K31/4184
Filed: 2004-09-22
Abstract: A combination comprising candesartan and rosuvastatin for the prevention or treatment of arteriosclerosis and for the prevention of cardiovascular events is described.
Patent CA-2541278-A1 (CA)
Title: Mobile-terminal gateway
Inventor: WESSLEN ANDERS
IPC: H04M1/724
Filed: 2004-10-08
Abstract: A mobile terminal includes an access subsystem and an application subsystem.  The access subsystem includes at least one access-technology interface. The application subsystem is inter-operably connected to the access subsystem. The application subsystem and the access subsystem are separated via a functional split. The access subsystem provides access by the application subsystem to a first wireless network via a first access-technology interface of the at least one access-technology interface.
Patent CA-2541563-A1 (CA)
Title: Method and system for digital training with internet video advertising
Inventor: FOX AEROCK
IPC: G09B5/08
Filed: 2006-03-31
Abstract: A method of using the Internet to facilitate training of students which permits students to learn skills and be critiqued on those skills by others, including skilled trainers, without being in the same physical location, by providing an Internet website which permits uploading and downloading of video files to both instruct the student and permit critique of the students' skills by others.
Patent CA-2544415-A1 (CA)
Title: Herbicidally active agent
Inventor: ROSINGER CHRISTOPHER
IPC: A01N43/42
Filed: 2004-10-21
Abstract: A herbicidally active agent containing (A), one or several sulfonyl ureas from a group consisting of metsulfuron, thifensulfuron, tribenuron, chlorosulfon and the salts and esters thereof and (B) one or several safeners from a group consisting of mefenpyr, isoxadifen, cloquintocet, fenchlorazol and the salts and esters thereof.
Patent CA-2545136-A1 (CA)
Title: Drug-eluting biodegradable stent
Inventor: TU HOSHENG
IPC: A61F2/92
Filed: 2004-11-05
Abstract: The present invention relates to a drug-loaded biodegradable stent and methods for treating vulnerable plaques of a patient comprising a plurality of layers or zones, each layer or zone comprising its own specific biodegradation rate and its specific drug loading characteristics. In one embodiment, the layers and zones are configured and arranged, in combination, radially, circumferentially and longitudinally.
Patent CA-2545287-A1 (CA)
Title: Access method between marine structures and apparatus
Inventor: GRINSTED TIMOTHY WILLIAM
IPC: B63B27/14
Filed: 2004-11-09
Abstract: Access means are provided for accessing a fixed offshore structure such as a wind turbine (70), larger vessel or the like form a smaller transfer vessel (50), or for providing for transfer between vessels. One or more guide wires (12) are connected from the vessel (50) to the fixed structure (70) or second vessel and placed in tension such as by directing the transfer vessel away from the fixed structure. In one embodiment, inflatable, members are suspendable from the guide wires and inflation of the inflatable members causes them to extend along the guide wires to form an access surface (56) across which personnel may walk to access the fixed structure or second vessel from the first vessel. Mounting means are also provided which accommodate relative rotational, translational and pitching movement of the apparatus and vessel, caused by wave motion. In another embodiment, a bridge member is retained on a runway of the first vessel and deployed using said guide wires (12).
Patent CA-2546294-A1 (CA)
Inventor: LABBE ETIENNE
IPC: A01D34/835
Filed: 2006-05-11
Abstract: The present invention relates to a brush cutting head for a brush cutter. Th e brush cutter head includes a cylindrical support body that has a first end, an opposed second end and an intermediate portion extending therebetween. The intermediate portion has a curved surface that defines the circular cross-section of the cylindrical support body. A plurality of collars is mounted to the cylindrical support body at spaced intervals along the intermediate portion. Each collar extends radially from the curved surface of the cylindrical support body. Additionally, each collar cooperates with an adjacent collar to define a mounting station between the adjacent collars. The brush cutter head further includes a plurality of cutting tooth assemblies carried on the outer surface of the cylindrical support body. Each cutting tooth assembly has a cutting tooth for placement within the mounting station and a mounting assembly engageable with the adjacent collars to secure the cutting tooth in the mounting station.
Patent CA-2546794-A1 (CA)
Inventor: STRATEN EIVIND PER THOR
IPC: G01N33/574
Filed: 2004-11-18
Abstract: The present invention relates to proteins belonging to the Bcl-2 family and peptides fragments thereof for use in pharmaceutical compositions. The disclosed proteins and peptide fragments are in particularly useful in vaccine compositions for treatment of cancer. The invention furthermore relates to methods of treatment using said compositions. It is also an aspect of the invention to provide T-cells and T-cell receptors specifically recognising the disclosed proteins and peptide fragments.
Patent CA-2553526-A1 (CA)
Inventor: DUNN MICHAEL H
IPC: G09F19/18
Filed: 2005-01-12
Abstract: An interactive display system is provided including a support frame having a vertical positioning element that counterbalances the weight of an attached interactive display, for example a touch-sensitive display. The support frame optionally includes a power supply increasing the range of mobility of the interactive display system by eliminating the need for power cord and power outlet connections. One exemplary support frame for an interactive display includes a base element, at least one support extending vertically from the base element, and a positioning element housed within the at least one support. The positioning element counterbalances the weight of the interactive display allowing vertical repositioning of the interactive display with a force of less than about 25 pounds.
Patent CA-2554534-A1 (CA)
Inventor: SUN WEN-JUN
IPC: C12Q1/02
Filed: 2005-01-31
Abstract: The present invention relates generally to a method for increasing the yield of plasmid DNA production. The method includes the steps of selecting a highly productive clonal subtype of a strain of E. coli, including but not limited to the DH5 strain, harboring a DNA plasmid and cultivating said clonal subtype with fed-batch fermentation in a chemically-defined medium. The plasmid DNA  production process described herein can generate record quantities of plasmid DNA when said highly productive clonal subtypes are cultivated on an industrial scale. The disclosed method can be used for the production of pharmaceutical grade DNA for use in polynucleotide vaccination and gene therapy treatment regimens.
Patent CA-2554738-A1 (CA)
Inventor: BLOOM DAVID RICHARD
IPC: A41B13/10
Filed: 2005-01-28
Abstract: An apron for use by dentists and the like is provided with a main body portion and a collar portion for securing the apron to the wearer in which the collar portion is adjustably securable at any position within a predetermined range such that it forms a close fit around the wearer wherein the collar and body portions comprise an absorbent side and a substantially waterproof.
Patent CA-2555381-A1 (CA)
Inventor: HEUER TIMOTHY S
IPC: G01N33/53
Filed: 2005-01-27
Abstract: Human ITPK genes are identified as modulators of the IGFR pathway and thus are therapeutic targets for disorders associated with defective IGFR function Methods for identifying modulators of IGFR comprising screening for agents that modulate the activity of ITPK are provided.
Patent CA-2555476-A1 (CA)
Title: Method for operating a fragmentation system and system therefor
Inventor: FREY WOLFGANG
IPC: B02C23/12
Filed: 2004-07-28
Abstract: The invention relates to a method for operating an electrodynamic fragmentation system. The fragmentation product arranged in the process fluid is permanently suspended and forms a suspension with the process fluid. The portion of the processed fragmentation product which attains the target particle size or smaller is discharged from the reaction vessel and the fragmentation product exceeding the target particle size is supplied to the reaction area. The fragmentation system comprises a chargeable electric energy store, a pair of electrodes connected thereto, and both ends thereof are arranged at a distance from each other in the process fluid contained in the reaction vessel. The fragmented product is separated in a solid and liquid manner in a separator in the electrode intermediate chamber until it reaches the target particle size and is smaller than the target particle size and the prepared process fluid is guided back into the reaction vessel.
Patent CA-2555684-A1 (CA)
Title: Crystal structures and models for fc receptors and uses thereof in the design or identification of fc receptor modulator compounds
Inventor: RAMSLAND PAUL ALLEN
IPC: C07K14/735
Filed: 2005-02-10
Abstract: The invention relates to the determination of the three-dimensional structures of Fc receptor proteins, particularly wild-type Fc.gamma.RIIa, by X-ray crystallography and the use of the structure in identifying and modifying agents for modulating the biological activity of Fc receptors. Also disclosed is a novel dimeric structure for Fc.gamma.RIIa and novel target sites for agents for modulating the biological activity of Fc receptor proteins.
Patent CA-2559759-A1 (CA)
Title: Insect control system
Inventor: ROBERTS MARILYN L
IPC: A01G13/02
Filed: 2006-09-15
Abstract: A control system for reducing or minimizing the damage to fruit and vegetable crops which occurs as a result of insects attacking the fruit or vegetables prior to it being hazvested. It includes a bag, ground cover and method for using the same.
Patent CA-2560404-A1 (CA)
Inventor: RUFENER JERRY
IPC: G06F16/93
Filed: 2006-09-21
Abstract: A document management technique includes a database of text strings, a document templates in the form of a doubly link or other list of text strings in the text string database which include attribute codes related to editing, approving, and displaying or printing test strings. Revised templates and text strings are saved as new templates and text strings so that the version of the document before any particular revision may easily be tracked and reproduced.
Patent CA-2566189-A1 (CA)
Inventor: GORWA-GRAUSLUND MARIE-FRANCOIS
IPC: C12P/
Filed: 2005-05-04
Abstract: The present invention relates to a new xylose utilizing Saccharomyces cerevisiae strain being able to utilize xylose for ethanol production which strain is up-regulated with regard to the genes for xylose reductase (XR) and xylulose dehydrogenase (XDH) as well as xululokinase (XK) and over-expressing the non-oxidative pentose phosphate pathway (PPP) and comprising a deletion of the gene GRE3 deletion, as well as the strain has been adapted to xylose feeding.
Patent CA-2567713-A1 (CA)
Inventor: STEINER PHILIP
IPC: G07B13/00
Filed: 2006-11-10
Abstract: There is provided an electronic taximeter that accepts a digital data input representative of one of a vehicle speed and a distance traveled by the vehicle. The digital data signal may be taken from the electronic engine bus of the vehicle or from the On Board Diagnostic connector. The taximeter has reading means to read the digital data input, timing means to provide timing data and computation means operatively connected to the reading means and the timing means for computing a fare associated with a trip. The computation means can advantageously be provided with speed integration means for integrating the speed data with respect to time, or summation means where the input is a digital distance, in order to determine the distance traveled by the vehicle with an accuracy meeting the regulations.
Patent CA-2571370-A1 (CA)
Inventor: ROUSSEAU FRANCIS
IPC: C12Q1/68
Filed: 2005-06-30
Abstract: The present invention discloses the identification of a human autism susceptibility gene, which can be used for the diagnosis, prevention and treatment of autism and related disorders, as well as for the screening of therapeutically active drugs. The invention more specifically discloses that the PRKCB 1 gene on chromosome 16 and certain alleles thereof are related to susceptibility to autism and represent novel targets for therapeutic intervention. The present invention relates to particular mutations in the PRKCBI gene and expression products, as well as to diagnostic tools and kits based on these mutations. The invention can be used in the diagnosis of predisposition to, detection, prevention and/or treatment of Asperger syndrome, pervasive developmental disorder, childhood disintegrative disorder, mental retardation, anxiety, depression, attention deficit hyperactivity disorders, speech delay or language impairment, epilepsy, metabolic disorder, immune disorder, bipolar disease and other psychiatric and neurological diseases.
Patent CA-2580243-A1 (CA)
Inventor: HERRMANN STEFAN
IPC: C07D409/14
Filed: 2005-09-15
Abstract: The invention relates to novel 5-heterocyclyl pyrimidines, several methods for the production thereof, and the use thereof for controlling unwanted microorganisms. The invention also relates to novel intermediate products and methods for the production thereof.
Patent CA-2581072-A1 (CA)
Title: Compounds for the treatment of dyslipidemia and other lipid disorders
Inventor: DROPINSKI JAMES F
IPC: C07D261/20
Filed: 2005-09-12
Abstract: A class of compounds having Formula (I) and pharmaceutically acceptable salts thereof are useful as therapeutic compounds, particularly in the treatment of hyperlipidemia, hypercholesterolemia, dyslipidemia, and other lipid disorders, and in delaying the onset of or reducing the risk of developing conditions and sequelae that are associated with these diseases, such as atherosclerosis.
Patent CA-2581295-A1 (CA)
Inventor: KIM JUNG-WON
IPC: H04W28/06
Filed: 2005-10-25
Abstract: Cette invention concerne un procédé et un système d'émission/réception d'un message à destination ou en provenance d'une station de base voisine dans un système d'accès sans fil à bande large. Une station de base fixe émet vers une station de base voisine un message d'information qui comprend un champ indicateur spécifique destiné à limiter les informations pour la station de base et un champ réservé, et omet des informations de station de base itératives en fonction de la valeur déterminée dans le champ indicateur spécifique, ce qui améliore l'efficacité de la transmission. Un terminal mobile reçoit le message d'information d'une station de base voisine, vérifie le message reçu et met à jour l'identité ID de l'opérateur en fonction de la valeur fixée dans le champ indicateur spécifique.
Patent CA-2582584-A1 (CA)
Title: Vented soffit assembly and method of installation
Inventor: COULTON MICHAEL S
IPC: E04D13/17
Filed: 2007-03-26
Abstract: A continuous, elongate, strip of openwork ventilation material is provided in roll form and is unrolled and installed in a soffit as a one-piece, continuous vent along a length of the soffit. The opposite longitudinally-extending side edges of the ventilation material are inserted within opposed, spaced-apart channels lining the periphery of the soffit opening or are provided with laterally-extending fastening strips that are fastened to boards lining the soffit opening.
Patent CA-2586510-A1 (CA)
Inventor: TIMPERLEY ANDREW JOHN
IPC: A61F2/34
Filed: 2007-04-26
Abstract: A prosthetic acetabular cup having a peripheral outwardly projecting flang e, the diametrical width of which is between 4 and 6 mm.